Mowad-Nassar Nicole, an insider at Resmed Inc (RMD), recently acquired 1,331 shares of the company at a price of $250.52 per share, totaling approximately $333,000. Following this transaction, Nicole holds the same number of shares in the company.
Resmed, headquartered in San Diego, California, specializes in digital health and cloud-connected medical devices, focusing on respiratory disorders, including sleep disordered breathing and chronic obstructive pulmonary disease. The company employs 10,600 full-time staff and operates in two main segments: Sleep and Breathing Health, and Residential Care Software. Its cloud-based software applications aim to enhance patient quality of life and support caregivers in various settings.
As of November 27, 2025, Resmed boasts a market capitalization of $37.2 billion, with a price-to-earnings ratio of 25.89 and an earnings per share of 9.77. The company also offers a notable dividend yield of 94.1%.
The upcoming earnings report is scheduled for April 21, 2026, with earnings per share expected at $2.80 and revenue projected at $1.4 billion. Insider purchases like this one may suggest confidence in the company's future, although they should be considered alongside broader market trends and other fundamental factors.